| Trial registration number
|
IRCT20210926052586N2 |
Full text link
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/62157
|
First author
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mojtaba Yousefi Zashk
|
Contact
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
dr.yousefi.md@ajaums.ac.ir
|
Registration date
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-02-26
|
Recruitment status
Last imported at : April 28, 2022, 3:41 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Hospitalization indication of Covid 19 patient
Indication for Remdesivir injection
Patient satisfaction to participate in this research project
Patients over 18 years old
|
Exclusion criteria
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Presence of underlying liver disease in the patient
Inability to receive oral drug
|
Number of arms
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Artesh University of Medical Sciences
|
Inclusion age min
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
100
|
Countries
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
80
|
primary outcome
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
The effect of melatonin with N-acetylcysteine in reducing liver injury caused by Remdesivir injection
|
Notes
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 4
|
Arms
Last imported at : Feb. 26, 2022, 7:30 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 2448, "treatment_name": "Melatonin+n-acetylcysteine", "treatment_type": "Central nervous system agents+respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|